Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune-tolerant phase-authors' reply

Aliment Pharmacol Ther. 2020 Sep;52(6):1094-1095. doi: 10.1111/apt.16000.

Authors

Han Ah Lee¹, Seung Up Kim^{2

3}

Affiliations

¹ Korea University College of Medicine, Seoul, Republic of Korea.
² Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.

PMID: 33119164
DOI: 10.1111/apt.16000

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Hepatitis B e Antigens
Hepatitis B virus
Hepatitis B, Chronic*
Humans
Liver Neoplasms*

Substances

Hepatitis B e Antigens